Dosimetric performance of Strut-Adjusted Volume Implant: A new single-entry multicatheter breast brachytherapy applicator

Brachytherapy

Volumn 10, Issue 2, 2011, Pages 128-135

  Gurdalli, Salih ^a   Kuske, Robert R ^a   Quiet, Coral A ^a   Ozer, Mustafa ^a  

^a Radiation Oncology/Brachytherapy   (United States)

Author keywords

Accelerated partial breast irradiation; Breast brachytherapy; SAVI

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; BREAST CARCINOMA; DOSIMETRY; FEMALE; HUMAN; IMPLANT; IRRADIATION; LUNG; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RADIATION DOSE; RIB; SKIN; STRUT ADJUSTED VOLUME IMPLANT; THORAX WALL;

ADULT; AGED; BRACHYTHERAPY; BREAST NEOPLASMS; CATHETERS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; PROSTHESIS IMPLANTATION; RADIOMETRY; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 79951576198     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2010.03.002     Document Type: Article

References (33)

1. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
2. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-1232.
3. Schnitt S.J., Hayman J., Gelman R., et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 1996, 77:1094-1100.
4. Clark R.M., McCulloch P.B., Levine M.N., et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992, 84:683-689.
5. Liljegren G., Holmberg L., Bergh J., et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 1999, 17:2326-2333.
6. Vicini F.A., Baglan K.L., Kestin L.L., et al. Accelerated treatment of breast cancer. J Clin Oncol 2001, 19:1993-2001. [Review].
7. Vicini F.A., Chen P., Wallace M., et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2007, 69:1124-1130.
8. Wazer D.E., Kaufman S., Cuttino L., et al. Accelerated partial breast irradiation: An analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2006, 64:489-495.
9. Wazer D.E., Berle L., Graham R., et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 2002, 53:889-897.
10. Arthur D.W., Winter K., Kuske R.R., et al. A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys 2008, 72:467-473.
11. Arthur D.W., Vicini F.A., Kuske R.R., et al. Accelerated partial breast irradiation: An updated report from the American Brachytherapy Society. Brachytherapy 2002, 1:184-190. Brachytherapy 2003;2:124-130.
12. Baglan K.L., Martinez A.A., Frazier R.C., et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2001, 50:1003-1011.
13. Baglan K.L., Sharpe M.B., Jaffray D., et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 2003, 55:302-311.
14. Ibbott G.S., Hanson W.F., O'Meara E., et al. Dose specification and quality assurance of radiation therapy oncology group protocol 95-17; A cooperative group study of iridium-192 breast implants as sole therapy. Int J Radiat Oncol Biol Phys 2007, 69:1572-1578.
15. Vicini F.A., Kestin L.L., Edmundson G., et al. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys 1999, 45:803-810.
16. Patel R.R., Becker S.J., Das R.K., et al. A dosimetric comparison of accelerated partial breast irradiation techniques: Multicatheter interstitial brachytherapy, three-dimensional conformal radiotherapy, and supine versus prone helical tomotherapy. Int J Radiat Oncol Biol Phys 2007, 68:935-942.
17. Das R.K., Patel R., Shah H., et al. 3D CT-based high-dose-rate breast brachytherapy implants: Treatment planning and quality assurance. Int J Radiat Oncol Biol Phys 2004, 59:1224-1228.
18. Kuske R.R., Winter K., Arthur D.W., et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys 2006, 65:45-51.
19. Vicini F., Beitsch P.D., Quiet C.A., et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 2008, 112:758-766.
20. Zannis V., Beitsch P., Vicini F., et al. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Am J Surg 2005, 190:530-538.
21. Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003, 55:289-293.
22. Jeruss J.S., Vicini F.A., Beitsch P.D., et al. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Ann Surg Oncol 2006, 13:967-976.
23. Benitez P.R., Keisch M.E., Vicini F., et al. Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 2007, 194:456-462.
24. Scanderbeg D., Yashar C., Rice R., et al. Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. Radiat Oncol 2009, 90:36-42.
25. Soran A., Evrensel T., Beriwal S., et al. Placement technique and the early complications of balloon breast brachytherapy: Magee-Women's Hospital experience. Am J Clin Oncol 2007, 30:152-155.
26. Yashar C.M., Blair S., Wallace A., et al. Initial clinical experience with the Strut-Adjusted Volume Implant brachtherapy applicator for accelerated partial breast irradiation. Brachytherapy 2009, 8:367-372.
27. Randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. NSABP protocol B-39, RTOG protocol 0413 Version: November 2, 2009.
28. Wu A., Ulin K., Sternick E.S. A dose homogeneity index for evaluating 192Ir interstitial breast implants. Med Phys 1988, 15:104-107.
29. Brashears J.H., Dragun A.E., Jenrette J.M. Late chest wall toxicity after Mammosite® breast brachytherapy. Brachytherapy 2009, 8:19-25.
30. Yorke E.D., Jakson A., Rosenweig K.E., Merrick S.A., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional radiation therapy. Int J Radiat Oncol Biol Phys 2002, 54:329-339.
31. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation induced pulmonary toxicity: A dose-volume histogram analysis in 201 patient with lung cancer. Int J Radiat Oncol Biol Phys 2001, 51:650-659.
32. McGale P., Darby S.C. Low doses of ionizing radiation and circulatory diseases: A systematic review of the published epidemiological evidence. Radiat Res 2005, 163:247-257.
33. Carr Z.A., Land C.E., Kleinerman R.A., et al. Coronary heart disease after radiotherapy for peptic ulcer disease. Int Radiat Oncol Biol Phys 2005, 61:842-850.